新型冠状病毒

UK set for Covid-19 vaccinations from ‘next week’ after regulatory approval

Emergency use of BioNTech/Pfizer jab authorised ahead of US and EU

The UK has become the first country to approve a Covid-19 vaccine following large-scale clinical trials and is set to make the shot from BioNTech and Pfizer available from “next week”.

Germany’s BioNTech and US pharma giant Pfizer said doses of the vaccine would be delivered to the UK in the coming days after the UK’s Medicines and Healthcare products Regulatory Agency gave the go-ahead on Tuesday evening.

The vaccine is 95 per cent effective in preventing the disease, according to data released last month from the companies’ phase-3 trial, which involved more than 43,000 people.

您已阅读24%(584字),剩余76%(1854字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归manbetx20客户端下载 所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×